Tradewinds Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-191
| Closed | -$12K | – | 694 |
|
|
2019
Q4 | $12K | Hold |
191
| – | – | ﹤0.01% | 384 |
|
|
2019
Q3 | $12K | Hold |
191
| – | – | ﹤0.01% | 352 |
|
|
2019
Q2 | $14K | Hold |
191
| – | – | 0.01% | 318 |
|
|
2019
Q1 | $15K | Hold |
191
| – | – | 0.01% | 325 |
|
|
2018
Q4 | $16K | Hold |
191
| – | – | 0.01% | 309 |
|
|
2018
Q3 | $33K | Hold |
191
| – | – | 0.01% | 254 |
|
|
2018
Q2 | $25K | Hold |
191
| – | – | 0.01% | 285 |
|
|
2018
Q1 | $20K | Hold |
191
| – | – | 0.01% | 300 |
|
|
2017
Q4 | $16K | Hold |
191
| – | – | 0.01% | 357 |
|
|
2017
Q3 | $16K | Hold |
191
| – | – | 0.01% | 337 |
|
|
2017
Q2 | $14K | Hold |
191
| – | – | 0.01% | 348 |
|
|
2017
Q1 | $13K | Buy |
+191
| New | +$13K | 0.01% | 361 |
|